Figure 6.

Systemic compositions of myeloid cell subsets. (A,B) Percentages of monocytes (CD11b⁺ CD66b^neg CD14⁺; red), neutrophils (CD11b⁺ CD66b⁺ CD14⁺; blue) and total granulocytes (CD11b⁺ CD66b⁺ CD14^neg, green), within CD11b⁺ cells. (C) Percentage of neutrophils in H-CoV and O-CoV. (D–F) Percentages of monocytes (CD11b⁺ CD66b^neg CD14⁺), neutrophils (CD11b⁺ CD66b⁺ CD14⁺) and granulocytes (CD11b⁺ CD66b⁺ CD14^neg) in the indicated groups. Statistical significance was evaluated by the Kruskal–Wallis test, followed by Dunn´s pair-wise comparisons. H-N/N—non-vaccinated, non-COVID-19 donors; H-CoV—healthy donors with previous COVID-19 infection; H-V—vaccinated healthy donor; H-CoV-V—vaccinated healthy donor with previous COVID-19; O-CoV—oncologic patient with previous COVID-19; O-V—vaccinated oncologic patients; O-CoV-V—vaccinated oncologic patients with previous COVID-19; *, ** and **** indicate significant (p < 0.05), very significant (p < 0.01) and very highly significant (p < 0.0001) differences, respectively.